Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Geron Corp (GERN)

Geron Corp (GERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Geron (GERN) Q3 2024 Earnings Call Transcript

GERN earnings call for the period ending September 30, 2024.

GERN : 3.49 (-4.64%)
Geron: Q3 Earnings Snapshot

Geron: Q3 Earnings Snapshot

GERN : 3.49 (-4.64%)
Is This Penny Stock With 55% Upside A Buy Now?

This biotech company currently has an approved product on the market. However, there is more to the story than meets the eye.

$SPX : 5,930.85 (+1.09%)
GERN : 3.49 (-4.64%)
Geron (GERN) Q2 2024 Earnings Call Transcript

GERN earnings call for the period ending June 30, 2024.

GERN : 3.49 (-4.64%)
Geron: Q2 Earnings Snapshot

Geron: Q2 Earnings Snapshot

GERN : 3.49 (-4.64%)
Is Geron Stock a Buy Following Its First New Drug Approval?

Find out if the high-flying biotech stock can keep on climbing higher.

AMGN : 263.38 (+0.84%)
GERN : 3.49 (-4.64%)
Geron (GERN) Q1 2024 Earnings Call Transcript

GERN earnings call for the period ending March 31, 2024.

GERN : 3.49 (-4.64%)
Geron: Q1 Earnings Snapshot

Geron: Q1 Earnings Snapshot

GERN : 3.49 (-4.64%)
Stock Index Futures Tick Higher Ahead of U.S. Economic Data, Fed Meeting Awaited

March S&P 500 E-Mini futures (ESH24) are up +0.20%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.14% this morning as investors looked ahead to a new round of U.S. economic data and geared up for...

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
LEN : 138.08 (-0.23%)
ON : 65.50 (+1.08%)
NVDA : 134.70 (+3.08%)
FSR : 0.0897 (-28.13%)
DKS : 218.76 (+0.54%)
VNA.D.DX : 29.450 (+2.40%)
VOD.LN : 66.500 (-0.84%)
GERN : 3.49 (-4.64%)
ADBE : 447.17 (+2.24%)
ULTA : 430.01 (+1.06%)
Geron (GERN) Q4 2023 Earnings Call Transcript

GERN earnings call for the period ending December 31, 2023.

GERN : 3.49 (-4.64%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar